Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
03/03/2023 21:34
March 3 (Reuters) - Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS INC - NASDAQ NOTIFIED CO THAT TRADING
IN
CO'S STOCK WILL BE SUSPENDED UPON OPENING OF BUSINESS ON MARCH
7, 2023
* RUBIUS THERAPEUTICS INC - NASDAQ WILL FILE A FORM 25 WITH
THE
SEC TO FORMALLY DELIST CO'S STOCK
* RUBIUS THERAPEUTICS INC - NASDAQ HAS NOT SPECIFIED THE
EXACT
DATE ON WHICH THE FORM 25 WILL BE FILED
Source text: [ID:http://bit.ly/3ERsFBO]
Further company coverage: RUBY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft